The Tandem Diabetes Treatment t:Slim X2 was authorised via the U.S. Food and Drug Administration in 2019 and is particularly the first insulin pump to become designated as an alternate controller enabled (ACE) insulin pump. ACE insulin pumps allow consumers to integrate steady glucose monitors, automated insulin dosing (AID) methods, together with